GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Poxel SA (XPAR:POXEL) » Definitions » Other Gross PPE

Poxel (XPAR:POXEL) Other Gross PPE : €2.63 Mil (As of Dec. 2022)


View and export this data going back to 2015. Start your Free Trial

What is Poxel Other Gross PPE?

Poxel's Other Gross PPE for the quarter that ended in Dec. 2022 was €2.63 Mil.

Poxel's quarterly Other Gross PPE declined from Dec. 2021 (€2.52 Mil) to Jun. 2022 (€1.57 Mil) but then increased from Jun. 2022 (€1.57 Mil) to Dec. 2022 (€2.63 Mil).

Poxel's annual Other Gross PPE declined from Dec. 2020 (€2.95 Mil) to Dec. 2021 (€2.52 Mil) but then increased from Dec. 2021 (€2.52 Mil) to Dec. 2022 (€2.63 Mil).


Poxel Other Gross PPE Historical Data

The historical data trend for Poxel's Other Gross PPE can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Poxel Other Gross PPE Chart

Poxel Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Other Gross PPE
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.24 2.62 2.95 2.52 2.63

Poxel Semi-Annual Data
Jun13 Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22
Other Gross PPE Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.95 1.97 2.52 1.57 2.63

Poxel Other Gross PPE Calculation

GuruFocus lists Land And Improvements, Buildings And Improvements, Machinery, Furniture, Equipment, Construction In Progress and Other Gross PPE under the "Gross Property, Plant and Equipment" section.


Poxel (XPAR:POXEL) Business Description

Traded in Other Exchanges
N/A
Address
259/261 Avenue Jean Jaures, Immeuble le Sunway, Lyon, FRA, 69007
Poxel SA is a biopharmaceutical company. It is focused on the development of novel treatments for metabolic diseases, including type 2 diabetes and liver diseases, such as nonalcoholic steatohepatitis (NASH) and rare disorders (ALD/AMN). It has developed a portfolio of drug candidates, including its candidates: Imeglimin, for the treatment of type 2 diabetes, and PXL770 and PXL065, for the treatment of NASH.

Poxel (XPAR:POXEL) Headlines

No Headlines